# Status Asthmaticus on the PICU; Intravenous Salbutamol

> **NCT03493503** · PHASE4 · COMPLETED · sponsor: **Erasmus Medical Center** · enrollment: 58 (actual)

## Conditions studied

- Childhood Asthma With Status Asthmaticus

## Interventions

- **DRUG:** Salbutamol
- **DRUG:** Sodium Chloride 0.9%

## Key facts

- **NCT ID:** NCT03493503
- **Lead sponsor:** Erasmus Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-05
- **Primary completion:** 2019-05-21
- **Final completion:** 2019-05-21
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2020-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03493503

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03493503, "Status Asthmaticus on the PICU; Intravenous Salbutamol". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03493503. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*